TRIM14 and acute myeloid leukemia: Besides, TRIM14 facilitated proliferation and restrain apoptosis of AML cells through the activation of PI3K/AKT pathway, while hMSC-Exos could reverse the effects of TRIM14 by delivering miR-23b-5p (Cheng et al., 2021).